News

Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.
Users of weight loss drugs such as Wegovy and Mounjaro, along with those who use type 2 diabetes drug Ozempic for weight loss ...
Eli Lilly's experimental weight loss pill, orforglipron, demonstrated an average weight loss of 12% in a late-stage trial, ...
A woman whose daughter nearly died after a liquid BBL (Brazilian butt lift) procedure says she is "disappointed and upset" ...
A string of blunders led to the value of Novo Nordisk plummeting last week. Could a new weight-loss pill help it regain its ...